Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
basic and moderately complex experiments using Molecular biology techniques (PCR, gel electrophoresis, DNA cloning) CRISPR techniques to disrupt targeted genes Microinjection, manipulation, and
-
Center. This position will organize and maintain multiple end user requests across Neuroscience community, including CRISPR screens, high throughput screens of neuronally differentiated iPSC cells
-
research involving molecular biology approaches (such as CRISPR/Cas technology, Western blotting, ELISA, immunohistochemistry), in vitro assays (such as drug screening, flow cytometry, development
-
, yeast and mammalian cells including primary cells from affected CDG patients.•The generation of cellular models using CRISPR/Cas9 gene-editing and other techniques.•Development and optimization
-
, or Pharmacology; - Demonstrated record of scientific achievements (publications and patents). Desired Qualifications: - Experience with gene editing (CRISPR), cellular and biochemical assays, cloning, expression
-
the field of research projects https://www.ncn.gov.pl/sites/default/files/pliki/uchwalyrady/2024/uchwa… Other criteria The perfect Candidate (F/M) is expected to: • have documented experience in
-
, Chikungunya, and yellow fever. The lab has developed CRISPR/Cas9 genome-editing in the Aedes aegypti mosquito with the goal of understanding how behaviors emerge from the integration of sensory input with
-
. Experience with molecular biology techniques, including DNA/RNA extractions; PCR; qPCR. Knowledge of functional genetics methods (e.g. CRISPR/CAS9; transgenesis). Knowledge of model organism biology
-
lab, gene editing, gene augmentation, CRISPR technologies, immunotherapy, and CAR-T cell therapy, designed to provide advanced scientific training while preparing students for highly valued professional
-
elements and regulatory factors control gene expression in both physiological and disease contexts. Current projects leverage ReLiC, a high-throughput CRISPR screening platform that we recently developed